Page last updated: 2024-08-17

egtazic acid and Stroke

egtazic acid has been researched along with Stroke in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bornstein, N; Diener, HC; Gorelick, PB; Lees, K; Rosenberg, G; Shuaib, A	1
Arba, F; Balami, JS; Buchan, AM; Kleinschnitz, C; Minnerup, J; Sutherland, BA	1
Bornstein, N; Diener, HC; Gorelick, PB; Lees, KR; Rosenberg, G; Shuaib, A	1

Reviews

1 review(s) available for egtazic acid and Stroke

Article	Year
Neuroprotection for ischaemic stroke: translation from the bench to the bedside. International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:5 Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical	2012

Article

Year

Neuroprotection for ischaemic stroke: translation from the bench to the bedside.

International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:5

Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical

2012

Trials

2 trial(s) available for egtazic acid and Stroke

Article	Year
The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study. International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chelating Agents; Double-Blind Method; Egtazic Acid; Female; Humans; Male; Middle Aged; Research Design; Stroke; Young Adult	2011
Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke. Stroke, 2013, Volume: 44, Issue:3 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Egtazic Acid; Endpoint Determination; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Time Factors; Treatment Outcome	2013

Article

Year

The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.

International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:4

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chelating Agents; Double-Blind Method; Egtazic Acid; Female; Humans; Male; Middle Aged; Research Design; Stroke; Young Adult

2011

Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.

Stroke, 2013, Volume: 44, Issue:3

Topics: Administration, Intravenous; Aged; Aged, 80 and over; Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Egtazic Acid; Endpoint Determination; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Time Factors; Treatment Outcome

2013